Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration

Authors not listed

Oxford BioMedica · 2012

Abstract

The purpose of this study is to examine the long term safety of an experimental gene transfer agent, RetinoStat®, designed to treat neovascular age-related macular degeneration.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Anonymous. (2012). A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration. <em>Oxford BioMedica</em>. https://clinicaltrials.gov/study/NCT01678872
Vancouver
Anonymous. A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration. Oxford BioMedica. 2012.
BibTeX
@misc{anon2012ALongT, title = {A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration}, author = {Anonymous}, journal = {Oxford BioMedica}, year = {2012}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings